In a recent study, Mansoori and coworkers (2020) tested the ability of hyaluronic acid-modified 5-fluorouracil (5-FU) -loaded, nanosized liposomes against colorectal cell lines (CD44-expressing) and a hepatoma cell line (non-CD44 expressing) [291]. Here, CD44 is linked to medical procedure.